News Releases

Alcresta Presents New Data at 28th Annual North American Cystic Fibrosis Conference (NACFC)

Oct 23, 2014

Demonstrating Potential of Proprietary Enzyme-Based Technology to Improve Nutrition in Patients with Exocrine Pancreatic Insufficiency

Alcresta Announces Agreement with Cystic Fibrosis Foundation Therapeutics

Apr 17, 2014

Agreement Highlights Importance of Medical Nutrition in Managing Cystic Fibrosis

Alcresta Launches Innovative Enzyme-Based Nutritional Company

Apr 17, 2012

Proprietary Platform for Nutritional Products that Improve Health and Manage Disease; Founded with New Synergistic Business Model by Proven Team and Top-Tier VCs